Simmons & Simmons appoints Pamela Kirby to board
This article was originally published in Scrip
International law firm, Simmons & Simmons, has appointed Pamela Kirby as a non-executive board member to create a board of ten. The board has responsibility for developing the firm's strategy and overseeing its implementation. Ms Kirby most recently served as CEO of Quintiles Translational Corp and is an experienced board director.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.